STRATA Skin Financials

SSKN Stock  USD 2.68  0.02  0.75%   
Based on the analysis of STRATA Skin's profitability, liquidity, and operating efficiency, STRATA Skin Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, STRATA Skin's Cash is very stable compared to the past year. As of the 23rd of March 2025, Cash And Short Term Investments is likely to grow to about 10.4 M, while Total Assets are likely to drop about 30.1 M. Key indicators impacting STRATA Skin's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio1.391.47
Notably Down
Slightly volatile
The essential information of the day-to-day investment outlook for STRATA Skin includes many different criteria found on its balance sheet. An individual investor should monitor STRATA Skin's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in STRATA Skin.

Net Income

(10.23 Million)

  

STRATA Skin Sciences Earnings Geography

STRATA Skin Stock Summary

STRATA Skin competes with Axogen, Ainos, LENSAR, Nexalin Technology, and Ainos. STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Strata Skin operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS86272A2069
CUSIP86272A206 55277R100 55277R308 86272A107 86272A305 285192100
LocationPennsylvania; U.S.A
Business Address5 Walnut Grove
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.strataskinsciences.com
Phone215 619 3200
CurrencyUSD - US Dollar

STRATA Skin Key Financial Ratios

STRATA Skin Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets46.8M46.6M52.3M42.0M48.3M30.1M
Retained Earnings(219.0M)(221.7M)(227.2M)(238.1M)(214.3M)(203.5M)
Total Current Assets24.8M20.0M17.5M15.5M17.9M17.2M
Other Current Assets7.8M924K2.7M1.6M1.9M1.1M
Total Liab20.9M21.2M30.4M29.3M33.7M35.4M
Other Current Liab1.6M2.4M2.5M2.0M2.3M1.4M
Net Debt278K(4.6M)3.0M8.8M10.2M10.7M
Cash10.6M12.6M5.4M6.8M6.1M10.1M
Accounts Payable2.8M2.8M3.4M3.3M3.8M2.5M
Other Assets428K347K1.3M216K248.4K301.5K
Net Receivables2.9M3.4M4.5M4.4M5.1M2.6M
Inventory3.4M3.5M5.5M2.7M3.1M3.3M
Short Term Debt9.1M636K710K352K316.8K301.0K
Intangible Assets6.3M10.1M17.4M7.3M8.4M5.6M
Other Liab499K178K288K666K765.9K1.1M
Net Tangible Assets12.7M11.9M10.7M6.5M5.9M6.7M

STRATA Skin Key Income Statement Accounts

202020212022202320242025 (projected)
Total Revenue23.1M30.0M36.2M33.4M38.4M19.5M
Gross Profit14.1M19.9M21.8M18.5M21.2M11.1M
Operating Income(4.1M)(4.4M)(4.6M)(8.6M)(7.7M)(8.1M)
Ebit(4.1M)(2.4M)(4.6M)(9.3M)(8.4M)(8.8M)
Research Development1.3M1.4M1.0M1.3M1.2M1.1M
Ebitda(165.0K)1.7M1.1M(3.4M)(3.9M)(4.1M)
Cost Of Revenue9.0M10.1M14.4M14.9M17.1M10.5M
Net Income(4.4M)(2.7M)(5.5M)(10.8M)(9.7M)(10.2M)
Income Tax Expense275K34K63K(92K)(105.8K)(111.1K)
Interest Expense211K314K926K1.6M1.9M1.3M
Income Before Tax(4.1M)(2.7M)(5.5M)(10.9M)(12.6M)(13.2M)
Tax Provision275K34K63K(92K)(82.8K)(78.7K)
Interest Income150K15K89K192K172.8K164.2K
Net Interest Income(61K)(299K)(837K)(1.2M)(1.4M)(1.4M)

STRATA Skin Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash2.5M(5.5M)(5.8M)1.3M1.2M814.7K
Free Cash Flow(63K)(2.1M)(4.7M)(5.5M)(6.4M)(6.7M)
Depreciation3.9M4.1M5.7M5.9M6.8M7.1M
Other Non Cash Items114K(1.9M)316K3.3M3.8M2.2M
Capital Expenditures2.2M3.7M3.6M5.0M5.8M6.1M
Net Income(4.4M)(2.7M)(5.5M)(10.8M)(12.5M)(13.1M)
End Period Cash Flow18.1M12.6M6.8M8.1M7.3M10.5M
Change To Inventory(417K)(45K)(1.5M)689K620.1K651.1K
Change To Netincome978K1.1M2.0M(233K)(209.7K)(199.2K)
Net Borrowings(3.4M)(296K)2.5M225K202.5K192.4K
Investments(2.2M)(7.1M)(4.2M)(4.7M)(4.2M)(4.4M)

STRATA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining STRATA Skin's current stock value. Our valuation model uses many indicators to compare STRATA Skin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STRATA Skin competition to find correlations between indicators driving STRATA Skin's intrinsic value. More Info.
STRATA Skin Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, STRATA Skin's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STRATA Skin's earnings, one of the primary drivers of an investment's value.

STRATA Skin's Earnings Breakdown by Geography

STRATA Skin Sciences Systematic Risk

STRATA Skin's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. STRATA Skin volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on STRATA Skin Sciences correlated with the market. If Beta is less than 0 STRATA Skin generally moves in the opposite direction as compared to the market. If STRATA Skin Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one STRATA Skin Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of STRATA Skin is generally in the same direction as the market. If Beta > 1 STRATA Skin moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in STRATA Skin Stock are looking for potential investment opportunities by analyzing not only static indicators but also various STRATA Skin's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of STRATA Skin growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0207)

At this time, STRATA Skin's Price Earnings To Growth Ratio is very stable compared to the past year.

STRATA Skin March 23, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of STRATA Skin help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of STRATA Skin Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of STRATA Skin Sciences based on widely used predictive technical indicators. In general, we focus on analyzing STRATA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build STRATA Skin's daily price indicators and compare them against related drivers.
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.53)
Revenue Per Share
8.978
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.09)
Return On Equity
(0.73)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.